Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AngioDynamics unveils new Morpheus SMART PICC system
The Morpheus SMART PICC 5F Dual Lumen Smart PICC power-injectable catheter power-injectable catheter is designed to provide a superior flow rate of 5ml/second for purposes of CT imaging.
The Morpheus SMART PICC 5F Dual Lumen Smart PICC power-injectable catheter power-injectable catheter is designed to provide a superior flow rate of 5ml/second for purposes of CT imaging.
The filing was accompanied by a priority review classification and a Prescription Drug User Fee Act (PDUFA) date of 17June, 2011. Apart from filing acceptance and assignment of
The team fabricated an electrically responsive nanoporous membrane based on polypyrrole doped with the dodecylbenzenesulfonate anions (PPy/DBS) which was electropolymerized to the top and upper side walls of
Pradaxa (dabigatran etexilate) is Boehringer Ingelheim’s novel, oral direct thrombin inhibitor for stroke risk reduction in patients with non-valvular atrial fibrillation (AF). According to a statement, the Washington-based
The patent also covers the polypeptide and nucleotide composition of matter for davunetide, its parent protein activity-dependent neuroprotective protein (ADNP) and other derivatives of ADNP. Currently, davunetide is
NU100 is a proprietary recombinant human interferon beta compound under development as a potential treatment for multiple sclerosis (MS) and will go into Phase III clinical trials in
The Phase II randomised clinical trial is designed to demonstrate the efficacy of adoptive cellular therapy for the pre-emptive treatment of cytomegalovirus (CMV) infections in patients who have
The ClinicalTrials.gov website is a registry of federally and privately supported clinical trials conducted in the US and around the world. The multi-centre, randomised, double-blind, placebo controlled Phase
Sodium thiopental is a sedative legally required for US lethal injections. In a statement, Novartis and Sandoz have said Sandoz has advised all its subsidiaries with locally approved
The trial is being conducted under the direction of James Cleary and George Cannon at the University of Wisconsin Carbone Cancer Center (UWCCC). ProCertus founder, chairman and chief